Investing.com

Will 'buying the dip' continue to be successful after the most accommodative Fed in history begins tightening? Major central banks, ECB, BOE, RBA all have interest rate decisions in the coming...

Stocks rallied on Friday, with the major averages notching their biggest one-day gain of the year to wrap up a rollercoaster week in financial markets.Highlighting the extreme volatility, the...

Earnings releases in the coming week from some of the largest US companies may help provide direction for investors at a time when the Federal Reserve’s shift to hiking rates is hurting...

Supply-chain issues dominated headlines in 2021. Since the early days of COVID-19, we have seen a ripple effect across global supply chains, restricting international trade flows. Bottlenecks...

What difference a week in ​​gold makes. Just last Friday, I remarked about gold’s sheer resilience in being able to hold to the key $1,800 an ounce level, despite the combined...

The combination of broad market risk-aversion and widespread concerns that stay-at-home stocks may have peaked has been taking a hefty toll on Netflix (NASDAQ:NFLX) shares. So far, the Los Gatos,...

Shares of artificial intelligence firm C3.ai are down more than 20% in January Despite recent overall declines in tech shares, C3.ai has also come under pressure following Q2 FY22 financials Long-term...

Investors looking for exposure to the foreign exchange (forex) market are increasingly researching currency exchange-traded funds (CETFs). As regular brokerage accounts can access these ETFs, retail...

As this January shapes into the month when Americans may use the most heating for a winter in seven years, energy traders are grappling with the question: Will the next few natural gas drawdowns from...

Reports Q1 2022 results on Thursday, Jan. 27, after the market close Revenue Expectation: $118.68 billion EPS Expectation: $1.89 When reporting quarterly earnings later today, Apple (NASDAQ:AAPL)...

Listen up, all you Bitcoin bulls who think this current rally is a return to happier days for cryptocurrencies. We're sorry to disappoint, but we anticipate the number-one digital token by market cap...

Pre-commercial biotech group Novavax’s stock is down more than 45% in January. The FDA has not yet authorized Novavax’s vaccine for use in the US. Long-term investors could consider buying...

Value stocks have been some of this year’s best performers as investors search for companies that benefit from the improving economic outlook at the expense of high-growth technology...

Volatility is back on Wall Street, just as many analysts predicted. The widely-followed VIX index is hovering around the 29 level, its highest in a year. Meanwhile, broader indices including the Dow...

For a fourth time in five months, cotton prices have hit decade highs. For investors, the question is simple: Will the market retreat meaningfully to allow an entry off its highs, and how much higher...

As the possibility of Russia invading Ukraine escalates, with the US ordering up its troops while NATO has placed its own forces on standby, the Russian ruble is currently being pressured by the...